We are live on ! Find out more
BRTX icon

BioRestorative Therapies
BRTX

13 hedge funds and large institutions have $412K invested in BioRestorative Therapies in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

0% more funds holding

Funds holding: 13 → 13 (0)

0.78% less ownership

Funds ownership: 4.07% → 3.3% (-0.78%)

54% less capital inflows, than outflows

Capital inflows: $26.2K | Capital outflows: $56.4K

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$20.9K
2
Raymond James Financial
Raymond James Financial
Florida
+$5.21K
3
Bank of America
Bank of America
North Carolina
+$35

Top Sellers

Rank Fund Capital Flow
1
SG
StoneX Group
New York
-$23.4K
2
UBS Group
UBS Group
Switzerland
-$14.5K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$9.97K
4
Morgan Stanley
Morgan Stanley
New York
-$5.21K
5
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$3.34K

BRTX Hedge Fund Activity: Q2 2025 in Review

13 of the 7,618 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q2 2025, worth a combined $412K — down 18% from $502K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new BRTX positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 4 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $20.9K. The largest seller was StoneX Group, cutting an estimated $23.4K.

  • 13 institutional investors held BioRestorative Therapies (BRTX) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $412K of BioRestorative Therapies stock for Q2 2025, down 18% quarter-over-quarter.
  • 2 funds opened new BioRestorative Therapies positions in Q2 2025 and 1 closed out, a net change of +1 holder.
  • The largest BioRestorative Therapies buyer in Q2 2025 was Virtu Financial, an estimated $20.9K added.
  • The largest BioRestorative Therapies seller in Q2 2025 was StoneX Group, an estimated $23.4K sold.

Based on aggregated 13F filings for Q2 2025.